Tower Research Capital (TRC)’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39K | Buy |
+195
| New | +$1.39K | ﹤0.01% | 4820 |
|
|
2024
Q4 | – | Sell |
-76
| Closed | -$4.89K | – | 5723 |
|
|
2024
Q3 | $4.89K | Sell |
76
-985
| -93% | -$63.4K | ﹤0.01% | 4386 |
|
|
2024
Q2 | $79.6K | Buy |
1,061
+880
| +486% | +$66K | ﹤0.01% | 2752 |
|
|
2024
Q1 | $21.6K | Buy |
181
+58
| +47% | +$6.92K | ﹤0.01% | 2935 |
|
|
2023
Q4 | $10.2K | Sell |
123
-76
| -38% | -$6.31K | ﹤0.01% | 4278 |
|
|
2023
Q3 | $15.7K | Buy |
199
+38
| +24% | +$3.01K | ﹤0.01% | 3598 |
|
|
2023
Q2 | $9.44K | Buy |
161
+9
| +6% | +$528 | ﹤0.01% | 4256 |
|
|
2023
Q1 | $7K | Sell |
152
-108
| -42% | -$4.97K | ﹤0.01% | 4724 |
|
|
2022
Q4 | $13K | Buy |
260
+210
| +420% | +$10.5K | ﹤0.01% | 3587 |
|
|
2022
Q3 | $5K | Sell |
50
-5
| -9% | -$500 | ﹤0.01% | 5129 |
|
|
2022
Q2 | $7K | Buy |
55
+27
| +96% | +$3.44K | ﹤0.01% | 4772 |
|
|
2022
Q1 | $6K | Buy |
28
+25
| +833% | +$5.36K | ﹤0.01% | 4859 |
|
|
2021
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6175 |
|
|
2021
Q2 | – | Sell |
-51
| Closed | -$25K | – | 5509 |
|
|
2021
Q1 | $25K | Buy |
+51
| New | +$25K | ﹤0.01% | 3702 |
|
|
2020
Q4 | – | Sell |
-19
| Closed | -$7K | – | 5144 |
|
|
2020
Q3 | $7K | Sell |
19
-7
| -27% | -$2.58K | ﹤0.01% | 4224 |
|
|
2020
Q2 | $10K | Buy |
+26
| New | +$10K | ﹤0.01% | 4001 |
|
|
2016
Q4 | – | Hold |
0
| – | -$2K | – | 3867 |
|
|
2016
Q3 | – | Hold |
0
| – | -$3K | – | 3040 |
|
|
2016
Q2 | – | Hold |
0
| – | -$3K | – | 3669 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3064 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4535 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4079 |
|
|
2015
Q2 | – | Hold |
0
| – | -$3K | – | 4447 |
|
|
2015
Q1 | – | Hold |
0
| – | -$1K | – | 3543 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3608 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4460 |
|